These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study. Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284 [TBL] [Abstract][Full Text] [Related]
3. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486 [TBL] [Abstract][Full Text] [Related]
4. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction. Chiva-Blanch G; Bratseth V; Laake K; Arnesen H; Solheim S; Schmidt EB; Badimon L; Seljeflot I Clin Nutr; 2021 Dec; 40(12):5674-5677. PubMed ID: 34742136 [TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial. Myhre PL; Berge T; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Solheim S; Arnesen H; Seljeflot I; Tveit A Clin Nutr; 2023 Sep; 42(9):1657-1660. PubMed ID: 37515843 [TBL] [Abstract][Full Text] [Related]
6. n-3 fatty acids and cardiovascular events after myocardial infarction. Kromhout D; Giltay EJ; Geleijnse JM; N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial. Yuan M; Zhang Y; Hua T; Liu XL; Liu T; Yuan RY; Li GP; Zhu Y; Zhang X Clin Nutr; 2021 Feb; 40(2):445-459. PubMed ID: 33041091 [TBL] [Abstract][Full Text] [Related]
8. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002 [TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC; J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344 [TBL] [Abstract][Full Text] [Related]
10. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147 [TBL] [Abstract][Full Text] [Related]
12. Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL. Majithia A; Bhatt DL; Friedman AN; Miller M; Steg PG; Brinton EA; Jacobson TA; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Budoff M; Preston Mason R; Tardif JC; Boden WE; Ballantyne CM Circulation; 2021 Nov; 144(22):1750-1759. PubMed ID: 34706555 [TBL] [Abstract][Full Text] [Related]
13. Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial. Bernhard B; Heydari B; Abdullah S; Francis SA; Lumish H; Wang W; Jerosch-Herold M; Harris WS; Kwong RY Int J Cardiol; 2024 Mar; 399():131698. PubMed ID: 38184150 [TBL] [Abstract][Full Text] [Related]
14. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J; Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071 [TBL] [Abstract][Full Text] [Related]
15. Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction. Greene SJ; Temporelli PL; Campia U; Vaduganathan M; Degli Esposti L; Buda S; Veronesi C; Butler J; Nodari S Am J Cardiol; 2016 Feb; 117(3):340-6. PubMed ID: 26708689 [TBL] [Abstract][Full Text] [Related]
16. REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States. Bhatt DL; Miller M; Brinton EA; Jacobson TA; Steg PG; Ketchum SB; Doyle RT; Juliano RA; Jiao L; Granowitz C; Tardif JC; Olshansky B; Chung MK; Gibson CM; Giugliano RP; Budoff MJ; Ballantyne CM; Circulation; 2020 Feb; 141(5):367-375. PubMed ID: 31707829 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence. Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE; Circ Res; 2020 Jan; 126(1):112-128. PubMed ID: 31895658 [TBL] [Abstract][Full Text] [Related]
18. Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients. Berge T; Myhre PL; Kalstad AA; Laake K; Tveit SH; Onarheim S; Solheim S; Seljeflot I; Arnesen H; Tveit A Cardiology; 2023; 148(1):72-77. PubMed ID: 36538900 [TBL] [Abstract][Full Text] [Related]